Line 243: | Line 243: | ||
<a href="#exp13"><h4>104. PCR of the new versions of C1 and C2 </h4></a><br/> | <a href="#exp13"><h4>104. PCR of the new versions of C1 and C2 </h4></a><br/> | ||
<a href="#exp14"><h4>105. PCR purification </h4></a><br/> | <a href="#exp14"><h4>105. PCR purification </h4></a><br/> | ||
− | <a href="#exp15"><h4>106. | + | <a href="#exp15"><h4>106. TOP 10 cells transformation with the TOPO cloning ligation product </h4></a><br/> |
<a href="#exp16"><h4>107. Dosage of C1 v2 and C2 v2 after PCR and purification </h4></a><br/> | <a href="#exp16"><h4>107. Dosage of C1 v2 and C2 v2 after PCR and purification </h4></a><br/> | ||
</p> | </p> | ||
Line 1,199: | Line 1,199: | ||
<th> Volume (μl) </th> | <th> Volume (μl) </th> | ||
<th> Insert </th> | <th> Insert </th> | ||
− | <th> Primer S </th> | + | <th> Primer S (For primer, see sequence in PCR protocol)</th> |
− | <th> Primer AS </th> | + | <th> Primer AS (Rev primer, see sequence in PCR protocol)</th> |
<th> Without DNA </th> | <th> Without DNA </th> | ||
</tr> | </tr> |